What You Should Know:
- L7 Informatics, a leader in software for life sciences that delivers a flexible end-to-end platform for precision healthcare, today announced a $38M investment led by Banneker Partners with participation from its pre-existing investors.
- The company will use the new funding to accelerate product development, expand L7|ESP's global reach, and build on L7's outstanding customer support.
Precision healthcare offers significant improvements in
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Insilico Medicine Raises $60M, Launches AI-powered Drug Discovery Robotics Laboratory
What You Should Know:
- Insilico Medicine, an NYC-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company raises $60 million in Series D financing from a syndicate of global investors with expertise in investing in the biopharmaceutical and life sciences sectors.
- Insilico is also launching a new state-of-the-art robotics lab and fully robotic biological data factory. They have seen a string of successes thus far in 2022, including the
Read More
Rocket VR Health Launches VR Mindfulness Program for Cancer Patients
What You Should Know:
- Rocket VR Health, a digital therapeutics company developing immersive therapy programs launches a new study in partnership with Dr. Linda Carlson, Enbridge Research Chair in Psychosocial Oncology at the University of Calgary Cumming School of Medicine.
- The first-of-its-kind study will assess the feasibility of a virtual reality guided mindfulness (VRGM) intervention program in adult cancer patients with chronic cancer-related pain
Read More
Watchmaker Genomics Raises $40M to Expand Clinical Sequencing Product Offerings
What You Should Know:
- Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA raises $40M in an oversubscribed Series A, bringing total funding to date to $53.5M. The round was led by Decheng Capital, with co-investment from Eclipse Ventures.
- Watchmaker Genomics applies advanced enzymology to enable breakthrough applications for the reading, writing, and
Read More
Tempus Launches Psychiatric Real-World Data Collaboration
What You Should Know:
- Tempus, an $8B precision medicine company, announced the launch of a new psychiatric real-world data program to leverage real-world data to inform mental health treatment.
- Tempus N+ is a collaboration between provider institutions across the country and Tempus to build an infrastructure for data-driven research – providers can seamlessly and securely contribute molecular and clinical data, and in turn, their clinicians and researchers can access a
Read More
Cerner Collaboration to Increase Access to Cancer Clinical Trials
What You Should Know:
- Cerner, Elligo Health Research® and Freenome are collaborating to enable a clinical trial through the Learning Health Network to help advance early cancer detection.
- Together they will be using the research-activated network of health systems, real-world data (RWD) and multiomics technology, developed by Freenome, with the goal to help accelerate early cancer detection.
Importance of Early Cancer Detection
Early
Read More
HealthQuest Capital Closes $675M for Fund IV to Invest in Transformational Healthcare Companies
What You Should Know:
- HealthQuest Capital, a sector specialist capital firm focused on companies optimizing value in healthcare, today announced the close of HealthQuest Partners IV, L.P., at its hard cap of $675M .
- The oversubscribed fund will enable HealthQuest to continue to invest in growth-stage companies that are revolutionizing the healthcare industry.
Providing Growth Capital to Companies Transforming Healthcare
Founded in 2013 by Garheng Kong, a physician, scientist, and
Read More
Delivering Patient-Centered Care Means Decluttering the Digital Health Landscape
Digital health companies (DHCs) and their solutions continue to grow at a rapid pace. This is in part being fueled by the record funding for DHCs, with over $29 billion for US-based companies in 2021 alone. As a result, patients are inundated with solutions from every direction – from employers, health plans, and directly through consumer-oriented apps and wearables. Physicians are also getting into the mix by directly prescribing digital therapeutics. On the surface, the blossoming of the
Read More
OncoHost Raises $35M for AI-Powered Precision Oncology Platform
What You Should Know:
- OncoHost, an AI-powered precision oncology platform, today announced a $35M Series C funding round led by ALIVE Israel HealthTech VC, as well as other prominent investors. Additional investors included leading Israeli financial firm Leumi Partners, Israel’s largest pension fund Menora Mivtachim, OurCrowd and other existing investors.
- The funding will go towards expanding OncoHost’s ongoing multicenter PROPHETIC trial as well as support its upcoming
Read More
Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic Medicines
What You Should Know:
- Kelonia Therapeutics, a Boston-based biotech company focused on vivo gene delivery, launched with a $50 million in Series A funding to expand the benefit and reach of genetic medicines.
- Despite life-changing responses, existing gene therapies are highly complex, costly, and limited by complicated treatment paradigms, tractable therapeutic applications, and dose-limiting toxicities. By enabling precisely targeted, highly efficient, manufacturable “off-the-shelf” in
Read More
